Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Intravenous Therapy And Vein Access Devices Market Forecast: What Value Will The Market Reach By 2030?#_x000D_
The intravenous therapy and vein access devices market has witnessed substantial growth in recent years. This market is expected to expand further, reaching $35.79 billion in 2026 from $33.15 billion in 2025, at a compound annual growth rate (CAGR) of 8.0%. Factors contributing to its historical growth include the limited accessibility of advanced IV therapy devices, a reliance on conventional catheters and needles, the expansion of hospital and clinic infrastructure, an increasing requirement for blood-based products and medication administration, and heightened awareness of infection control protocols._x000D_
_x000D_
The intravenous therapy and vein access devices market size is anticipated to undergo significant expansion in the coming years. It will grow to $48.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is driven by the development of implantable ports and advanced infusion pumps, the rising adoption of needleless connectors and IV administration sets, the proliferation of ambulatory surgical centers, the integration of smart monitoring and digital solutions, and increasing investment in patient safety and regulatory compliance. Major trends expected in this period include a rising demand for peripheral and central venous access devices, an increasing uptake of safety-engineered needles and catheters, growth in infusion pump technologies and patient-controlled analgesia systems, the expansion of nutrition and medication administration applications, and an enhanced focus on sterility, accuracy, and regulatory compliance._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Intravenous Therapy And Vein Access Devices Market Demand Drivers Opening New Revenue Streams#_x000D_
The future expansion of the intravenous therapy and vein access devices market is anticipated to be driven by the rising volume of surgical procedures. This market improvement is fueled by the escalating need for elective surgeries, including cosmetic procedures, plastic surgery, and rhinoplasty, among other non-essential operations. These devices play a crucial role during surgeries by facilitating the delivery of anesthesia, medications, fluids, and nutrients, thereby maintaining patient stability and enabling swift intervention as required. An illustrative example comes from June 2024, where the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit professional organization, reported a 3.4% increase in overall surgical and non-surgical procedures in 2023, totaling 34.9 million. This particular expansion was primarily propelled by a 5.5% increase in surgical procedures. Over the last four years, plastic surgeons conducted more than 15.8 million surgical procedures and 19.1 million non-surgical procedures, signifying a 40% cumulative rise in procedures. Consequently, the growing volume of surgical operations is a key factor propelling the intravenous therapy and vein access devices market forward._x000D_
_x000D_
#Intravenous Therapy And Vein Access Devices Market Segment Landscape And Growth Outlook#_x000D_
The intravenous therapy and vein access devices market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Intravenous (IV) Therapy And Vein Access Implantable Ports, Intravenous (IV) Therapy And Vein Access Intravenous Catheters, Hypodermic Intravenous (IV) Therapy And Vein Access Needles, Intravenous (IV) Therapy And Vein Access Infusion Pumps, Other Types_x000D_
2) By Application: Volume Expanders, Medication Administration, Blood-Based Products, Nutrition And Buffer Solutions_x000D_
3) By End Use: Hospitals, Clinics, Ambulatory Surgical Centers_x000D_
_x000D_
Subsegments:_x000D_
1) By Intravenous (IV) Therapy And Vein Access Implantable Ports: Single-Lumen Implantable Ports, Double-Lumen Implantable Ports, Triple-Lumen Implantable Ports _x000D_
2) By Intravenous (IV) Therapy And Vein Access Intravenous Catheters: Peripheral IV Catheters, Central Venous Catheters (CVC), Peripherally Inserted Central Catheters (PICC), Tunneled Catheters _x000D_
3) By Hypodermic Intravenous (IV) Therapy And Vein Access Needles: Standard Hypodermic Needles, Butterfly Needles, Safety Hypodermic Needles _x000D_
4) By Intravenous (IV) Therapy And Vein Access Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps, Ambulatory Infusion Pumps _x000D_
5) By Other Types: IV Administration Sets, IV Fluid Bags And Tubing, Needleless Connectors, IV Drip Chambers_x000D_
_x000D_
#Intravenous Therapy And Vein Access Devices Market Trends Powering Strategic Industry Growth#_x000D_
Major companies engaged in the intravenous therapy and vein access devices market are innovating short peripheral intravenous catheters to enhance patient comfort, reduce insertion-related complications, and improve the efficiency of fluid and medication delivery. These catheters offer a swift and effective method for delivering fluids, medications, and nutrients directly into the bloodstream, thereby minimizing patient discomfort, lowering the risk of infection, and providing easy and dependable venous access for a variety of medical treatments. For instance, in October 2023, B. Braun, a Germany-based medical device company, launched the Introcan Safety 2 IV Catheter, a short peripheral intravenous catheter featuring passive needlestick prevention and a Multi-Access blood control septum. This advanced catheter is engineered to improve clinician safety through automatic needlestick protection and a blood control feature that minimizes exposure to bloodborne pathogens every time the hub is accessed._x000D_
_x000D_
#Intravenous Therapy And Vein Access Devices Market Leading Companies And Competitive Benchmarking#_x000D_
Major companies operating in the intravenous therapy and vein access devices market are Cardinal Health Inc., Johnson & Johnson Services Inc., 3M Company, Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., Teleflex Incorporated, Smiths Medical, Nipro Corporation, Argon Medical Devices Inc., Angiplast Private Limited, Poly Medicure Limited, Iradimed Corporation _x000D_
_x000D_
#View The Full Intravenous Therapy And Vein Access Devices Market Report:#_x000D_
_x000D_
#Intravenous Therapy And Vein Access Devices Market Top Region By Revenue And Market Share#_x000D_
North America was the largest region in the intravenous therapy and vein access devices market in 2025. The regions covered in the intravenous therapy and vein access devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model